A dual-threshold non-invasive strategy is established for predicting HRPCa in biopsy-free radical prostatectomy candidates pre-screened by the USTC model, while its applicability to unscreened or low to intermediate-risk populations remains unproven.
Liang et al. (Mon,) studied this question.